Bridgeway Capital Management, LLC Vigil Neuroscience, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.71 - $3.03 $34,542 - $61,205	-20,200 Reduced 20.19%	79,864 $142,000
Q4 2024 Feb 14, 2025	SELL	$1.53 - $4.0 $7,650 - $20,000	-5,000 Reduced 4.76%	100,064 $168,000
Q3 2024 Nov 14, 2024	BUY	$2.92 - $4.65 $73,000 - $116,250	25,000 Added 31.23%	105,064 $357,000
Q2 2024 Aug 14, 2024	BUY	$2.51 - $4.66 $55,470 - $102,986	22,100 Added 38.13%	80,064 $320,000
Q1 2024 May 15, 2024	SELL	$2.68 - $3.63 $201,000 - $272,250	-75,000 Reduced 56.41%	57,964 $197,000

Q4 2023 Feb 14, 2024	BUY	$2.97 - $8.6 $394,903 - $1.14 Million	132,964 New	132,964 $449,000

4.69M

Ticker VIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,268,600
Market Cap $228M
Description
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.